| Authors: |
Stein Gold LF; Department of Dermatology, Henry Ford Hospital, Detroit, MI, USA., Bagel J; Psoriasis Treatment Center of New Jersey, East Windsor, NJ, USA., Tyring SK; Department of Dermatology, Microbiology and Molecular Genetics and Internal Medicine, The University of Texas Medical School at Houston, Houston, TX, USA., Hong HC; Department of Dermatology and Skin Science, University of British Columbia, Vancouver, BC, Canada.; Probity Medical Research, Surrey, BC, Canada., Pavlovsky L; Tel Aviv University, Tel Aviv, Israel.; Rabin Medical Centre, Petah Tikva, Israel., Vender R; Dermatrials Research, Hamilton, ON, Canada.; Venderm Consulting, Hamilton, ON, Canada., Pinter A; Department of Dermatology, University Hospital Frankfurt am Main, Frankfurt am Main, Germany., Reich A; Department of Dermatology, Institute of Medical Sciences, Medical College of Rzeszów University, Rzeszów, Poland., Drogaris L; AbbVie Inc., North Chicago, IL, USA., Wu T; AbbVie Inc., North Chicago, IL, USA., Patel M; AbbVie Inc., North Chicago, IL, USA., Soliman AM; AbbVie Inc., North Chicago, IL, USA., Photowala H; AbbVie Inc., North Chicago, IL, USA., Stakias V; AbbVie Inc., North Chicago, IL, USA., Richter S; AbbVie Inc., North Chicago, IL, USA., Papp KA; Probity Medical Research and Alliance Clinical Trials, Waterloo, ON, USA.; Division of Dermatology, Department of Medicine, University of Toronto, Toronto, ON, Canada. |
